SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mathieu Gerfaud-Valentin, Yvan Jamilloux, Jean Iwaz, Pascal Sève, Adult-onset Still's disease, Autoimmunity Reviews, 2014, 13, 7, 708

    CrossRef

  2. 2
    Colleen K. Correll, Bryce A. Binstadt, Advances in the pathogenesis and treatment of systemic juvenile idiopathic arthritis, Pediatric Research, 2014, 75, 1-2, 176

    CrossRef

  3. 3
    Annet van Royen-Kerkhof, Bas SJ Vastert, Joost F Swart, Nico M Wulffraat, Biologic treatment of pediatric rheumatic diseases: are we spoilt for choice?, Immunotherapy, 2014, 6, 1, 1

    CrossRef

  4. 4
    Mileka Gilbert, Marilynn Punaro, Blood gene expression profiling in pediatric systemic lupus erythematosus and systemic juvenile idiopathic arthritis: from bench to bedside, Pediatric Rheumatology, 2014, 12, 1, 16

    CrossRef

  5. 5
    Luca Cantarini, Giuseppe Lopalco, Francesco Caso, Luisa Costa, Florenzo Iannone, Giovanni Lapadula, Maria Grazia Anelli, Rossella Franceschini, Cristina Menicacci, Mauro Galeazzi, Carlo Selmi, Donato Rigante, Effectiveness and tuberculosis-related safety profile of interleukin-1 blocking agents in the management of Behçet's disease, Autoimmunity Reviews, 2014,

    CrossRef

  6. 6
    Sebastiaan J. Vastert, Wilco Jager, Bo Jan Noordman, Dirk Holzinger, Wietse Kuis, Berent J. Prakken, Nico M. Wulffraat, Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis: Results of a Prospective Cohort Study, Arthritis & Rheumatology, 2014, 66, 4
  7. 7
    Sebastiaan J Vastert, Joost F Swart, Nico M Wulffraat, Evaluation of anakinra for the treatment of systemic juvenile idiopathic arthritis, Expert Opinion on Orphan Drugs, 2014, 2, 2, 181

    CrossRef

  8. 8
    Clara Malattia, Alberto Martini, Glucocorticoids in juvenile idiopathic arthritis, Annals of the New York Academy of Sciences, 2014, 1318, 1
  9. 9
    Stephanie McCarty, William Frishman, Interleukin 1β, Cardiology in Review, 2014, 22, 4, 176

    CrossRef

  10. 10
    Grant S. Schulert, Alexei A. Grom, Macrophage activation syndrome and cytokine-directed therapies, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 277

    CrossRef

  11. 11
    G. Horneff, Moderne Behandlung der juvenilen idiopathischen Arthritis, Monatsschrift Kinderheilkunde, 2014, 162, 8, 693

    CrossRef

  12. 12
    E. S. Sen, A. V. Ramanan, New age of biological therapies in paediatric rheumatology, Archives of Disease in Childhood, 2014, 99, 7, 679

    CrossRef

  13. 13
    Norman T. Ilowite, Kristi Prather, Yuliya Lokhnygina, Laura E. Schanberg, Melissa Elder, Diana Milojevic, James W. Verbsky, Steven J. Spalding, Yukiko Kimura, Lisa F. Imundo, Marilynn G. Punaro, David D. Sherry, Stacey E. Tarvin, Lawrence S. Zemel, James D. Birmingham, Beth S. Gottlieb, Michael L. Miller, Kathleen O'Neil, Natasha M. Ruth, Carol A. Wallace, Nora G. Singer, Christy I. Sandborg, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis, Arthritis & Rheumatology, 2014, 66, 9
  14. 14
    Claudia Castiblanco, C. Stephen Foster, Review of Systemic Immunosuppression for Autoimmune Uveitis, Ophthalmology and Therapy, 2014,

    CrossRef

  15. 15
    Peter A. Nigrovic, Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?, Arthritis & Rheumatology, 2014, 66, 6
  16. 16
    Elizabeth A. Kessler, Mara L. Becker, Therapeutic advancements in juvenile idiopathic arthritis, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 293

    CrossRef

  17. 17
    Surender Rajasekaran, Katherine Kruse, Karen Kovey, Alan T. Davis, Nabil E. Hassan, Akunne N. Ndika, Sandra Zuiderveen, James Birmingham, Therapeutic Role of Anakinra, an Interleukin-1 Receptor Antagonist, in the Management of Secondary Hemophagocytic Lymphohistiocytosis/Sepsis/Multiple Organ Dysfunction/Macrophage Activating Syndrome in Critically Ill Children*, Pediatric Critical Care Medicine, 2014, 15, 5, 401

    CrossRef

  18. 18
    Matthew L Stoll, Randy Q Cron, Treatment of juvenile idiopathic arthritis: a revolution in care, Pediatric Rheumatology, 2014, 12, 1, 13

    CrossRef

  19. 19
    Sebastiaan Vastert, Berent Prakken, Update on research and clinical translation on specific clinical areas: From bench to bedside: How insight in immune pathogenesis can lead to precision medicine of severe juvenile idiopathic arthritis, Best Practice & Research Clinical Rheumatology, 2014, 28, 2, 229

    CrossRef

  20. 20
    Marilynn Punaro, Use of microarrays in the clinical practice of pediatric rheumatology, Current Opinion in Rheumatology, 2014, 26, 5, 585

    CrossRef

  21. 21
    Clara Malattia, Alberto Martini, The Autoimmune Diseases, 2014,

    CrossRef

  22. 22
    Sarah Ringold, Pamela F. Weiss, Timothy Beukelman, Esi Morgan DeWitt, Norman T. Ilowite, Yukiko Kimura, Ronald M. Laxer, Daniel J. Lovell, Peter A. Nigrovic, Angela Byun Robinson, Richard K. Vehe, 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications, Arthritis Care & Research, 2013, 65, 10
  23. 23
    F. McErlane, H. E. Foster, R. Davies, M. Lunt, K. D. Watson, D. P. M. Symmons, K. L. Hyrich, Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 2013, 52, 10, 1905

    CrossRef

  24. 24
    Nico M Wulffraat, Patricia Woo, Canakinumab in pediatric rheumatic diseases, Expert Opinion on Biological Therapy, 2013, 13, 4, 615

    CrossRef

  25. 25
    Femke H. M. Prince, Lisette W. A. van Suijlekom-Smit, Cost of Biologics in the Treatment of Juvenile Idiopathic Arthritis: A Factor not to be Overlooked, Pediatric Drugs, 2013, 15, 4, 271

    CrossRef

  26. 26
    M. H. Otten, J. Anink, S. Spronk, L. W. A. van Suijlekom-Smit, Efficacy of biological agents in juvenile idiopathic arthritis: a systematic review using indirect comparisons, Annals of the Rheumatic Diseases, 2013, 72, 11, 1806

    CrossRef

  27. 27
    Roberta A Berard, Ronald M Laxer, Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis, Expert Opinion on Biological Therapy, 2013, 13, 11, 1623

    CrossRef

  28. 28
    Aimalie L Hardaway, Izabela Podgorski, IL-1β, RAGE and FABP4: targeting the dynamic trio in metabolic inflammation and related pathologies, Future Medicinal Chemistry, 2013, 5, 10, 1089

    CrossRef

  29. 29
    Andreas Woerner, Nicole Ritz, Infections in Children Treated With Biological Agents, The Pediatric Infectious Disease Journal, 2013, 32, 3, 284

    CrossRef

  30. 30
    Monika Moll, Jasmin B. Kuemmerle-Deschner, Inflammasome and cytokine blocking strategies in autoinflammatory disorders, Clinical Immunology, 2013, 147, 3, 242

    CrossRef

  31. 31
    Dawn M Wahezi, Norman T Ilowite, Juvenile idiopathic arthritis: an update on current pharmacotherapy and future perspectives, Expert Opinion on Pharmacotherapy, 2013, 14, 8, 975

    CrossRef

  32. 32
    Daniel J. Lovell, Edward H. Giannini, Andreas O. Reiff, Yukiko Kimura, Suzanne Li, Philip J. Hashkes, Carol A. Wallace, Karen B. Onel, Dirk Foell, Richard Wu, Stephanie Biedermann, Jennifer D. Hamilton, Allen R. Radin, Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis, Arthritis & Rheumatism, 2013, 65, 9
  33. 33
    Friso G.J. Calkoen, Danielle M.C. Brinkman, Carly Vervat, Monique M. van Ostaijen-ten Dam, Rebecca ten Cate, Maarten J.D. van Tol, Lynne M. Ball, Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responses, Cytotherapy, 2013, 15, 3, 280

    CrossRef

  34. 34
    Yukiko Kimura, Jennifer E. Weiss, Kathryn L. Haroldson, Tzielan Lee, Marilynn Punaro, Sheila Oliveira, Egla Rabinovich, Meredith Riebschleger, Jordi Antón, Peter R. Blier, Valeria Gerloni, Melissa M. Hazen, Elizabeth Kessler, Karen Onel, Murray H. Passo, Robert M. Rennebohm, Carol A. Wallace, Patricia Woo, Nico Wulffraat, Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis, Arthritis Care & Research, 2013, 65, 5
  35. 35
    Sule Unal, Gunay Balta, Hamza Okur, Selin Aytac, Mualla Cetin, Fatma Gumruk, Seza Ozen, Aytemiz Gurgey, Recurrent Macrophage Activation Syndrome Associated With Heterozygous Perforin W374X Gene Mutation in a Child with Systemic Juvenile Idiopathic Arthritis, Journal of Pediatric Hematology/Oncology, 2013, 35, 5, e205

    CrossRef

  36. 36
    Seth L. Masters, Specific inflammasomes in complex diseases, Clinical Immunology, 2013, 147, 3, 223

    CrossRef

  37. 37
    Charles A. Dinarello, Jos W.M. van der Meer, Treating inflammation by blocking interleukin-1 in humans, Seminars in Immunology, 2013, 25, 6, 469

    CrossRef

  38. 38
    Matthew L. Stoll, Randy Q. Cron, Treatment of Juvenile Idiopathic Arthritis in the Biologic Age, Rheumatic Disease Clinics of North America, 2013, 39, 4, 751

    CrossRef

  39. 39
    Gerd Horneff, Update on biologicals for treatment of juvenile idiopathic arthritis, Expert Opinion on Biological Therapy, 2013, 13, 3, 361

    CrossRef

  40. 40
    Julia G. Harris, Elizabeth A. Kessler, James W. Verbsky, Update on the Treatment of Juvenile Idiopathic Arthritis, Current Allergy and Asthma Reports, 2013, 13, 4, 337

    CrossRef

  41. 41
    Joost F Swart, Sytze de Roock, Nico M Wulffraat, What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?, Arthritis Research & Therapy, 2013, 15, 3, 213

    CrossRef

  42. 42
    Joyce J. Hsu, Tzielan Chang Lee, Christy I. Sandborg, Kelley's Textbook of Rheumatology, 2013,

    CrossRef

  43. 43
    Christy Sandborg, Elizabeth D. Mellins, A New Era in the Treatment of Systemic Juvenile Idiopathic Arthritis, New England Journal of Medicine, 2012, 367, 25, 2439

    CrossRef

  44. 44
    Nicolino Ruperto, Pierre Quartier, Nico Wulffraat, Patricia Woo, Angelo Ravelli, Richard Mouy, Brigitte Bader-Meunier, Sebastiaan J. Vastert, Emanuele Noseda, Daniele D'Ambrosio, Jean Lecot, Abhijit Chakraborty, Alberto Martini, Andrea Chioato, A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features, Arthritis & Rheumatism, 2012, 64, 2
  45. 45
    Clio P. Mavragani, Evangelos G. Spyridakis, Michael Koutsilieris, Adult-Onset Still’s Disease: From Pathophysiology to Targeted Therapies, International Journal of Inflammation, 2012, 2012, 1

    CrossRef

  46. 46
    Claudia Macaubas, Khoa D. Nguyen, Ariana Peck, Julia Buckingham, Chetan Deshpande, Elizabeth Wong, Heather C. Alexander, Sheng-Yung Chang, Ann Begovich, Yue Sun, Jane L. Park, Kuang-Hung Pan, Richard Lin, Chih-Jian Lih, Erin M. Augustine, Carolyn Phillips, Andreas V. Hadjinicolaou, Tzielan Lee, Elizabeth D. Mellins, Alternative activation in systemic juvenile idiopathic arthritis monocytes, Clinical Immunology, 2012, 142, 3, 362

    CrossRef

  47. 47
    Yanhong Cao, Yan Jiao, Lishi Wang, Yue Huang, Arnold Postlethwaite, John Stuart, Andy Kang, Robert W. Williams, Weikuan Gu, Anakinra as an interleukin 1 receptor antagonist, complicated genetics and molecular impacts- from the point of view of mouse genomics, International Immunopharmacology, 2012, 13, 1, 28

    CrossRef

  48. 48
    C. M. Hedrich, N. Bruck, B. Fiebig, M. Gahr, Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA), Rheumatology International, 2012, 32, 11, 3525

    CrossRef

  49. 49
    Jacques Pouchot, Jean-Benoît Arlet, Biological treatment in adult-onset Still's disease, Best Practice & Research Clinical Rheumatology, 2012, 26, 4, 477

    CrossRef

  50. 50
    Xuefeng B Ling, Claudia Macaubas, Heather C Alexander, Qiaojun Wen, Edward Chen, Sihua Peng, Yue Sun, Chetan Deshpande, Kuang-Hung Pan, Richard Lin, Chih-Jian Lih, Sheng-Yung P Chang, Tzielan Lee, Christy Sandborg, Ann B Begovich, Stanley N Cohen, Elizabeth D Mellins, Correlation analyses of clinical and molecular findings identify candidate biological pathways in systemic juvenile idiopathic arthritis, BMC Medicine, 2012, 10, 1, 125

    CrossRef

  51. 51
    Takako Miyamae, Cryopyrin-Associated Periodic Syndromes, Pediatric Drugs, 2012, 14, 2, 109

    CrossRef

  52. 52
    Katherine Anne B. Marzan, Bracha Shaham, Early Juvenile Idiopathic Arthritis, Rheumatic Disease Clinics of North America, 2012, 38, 2, 355

    CrossRef

  53. 53
    Yanhong Ma, Xiaoyan Yan, Huakun Zhao, Wei Wang, Effects of Interleukin-1 Receptor Antagonist on Collagen and Matrix Metalloproteinases in Stress-shielded Achilles Tendons of Rats, Orthopedics, 2012, 35, 8, e1238

    CrossRef

  54. 54
    Linda Rossi-Semerano, Isabelle Koné-Paut, Focus sur les inhibiteurs de l’interleukine 1, Revue du Rhumatisme Monographies, 2012, 79, 1, 46

    CrossRef

  55. 55
    Yury Chaly, Anthony D. Marinov, Leif Oxburgh, Daniel S. Bushnell, Raphael Hirsch, FSTL1 promotes arthritis in mice by enhancing inflammatory cytokine/chemokine expression, Arthritis & Rheumatism, 2012, 64, 4
  56. 56
    Claire Larroche, Hemophagocytic lymphohistiocytosis in adults: Diagnosis and treatment, Joint Bone Spine, 2012, 79, 4, 356

    CrossRef

  57. 57
    K. Krause, C. E. Grattan, C. Bindslev-Jensen, M. Gattorno, T. Kallinich, H. D. Koning, H. J. Lachmann, D. Lipsker, A. A. Navarini, A. Simon, C. Traidl-Hoffmann, M. Maurer, How not to miss autoinflammatory diseases masquerading as urticaria, Allergy, 2012, 67, 12
  58. 58
    D. Lipsker, C. Lenormand, Indications et modalités d’utilisation des antagonistes de l’interleukine (IL)-1 dans les dermatoses inflammatoires, Annales de Dermatologie et de Vénéréologie, 2012, 139, 6-7, 459

    CrossRef

  59. 59
    Jeffrey H. Dunn, Lixia Z. Ellis, Mayumi Fujita, Inflammasomes as molecular mediators of inflammation and cancer: Potential role in melanoma, Cancer Letters, 2012, 314, 1, 24

    CrossRef

  60. 60
    Linda Rossi-Semerano, Isabelle Koné-Paut, Is Still's Disease an Autoinflammatory Syndrome?, International Journal of Inflammation, 2012, 2012, 1

    CrossRef

  61. 61
    Peter J. Gowdie, Shirley M.L. Tse, Juvenile Idiopathic Arthritis, Pediatric Clinics of North America, 2012, 59, 2, 301

    CrossRef

  62. 62
    Claire Larroche, Le syndrome d’activation macrophagique acquis de l’adulte : comment le reconnaître et le traiter ?, Revue du Rhumatisme, 2012, 79, 3, 194

    CrossRef

  63. 63
    Bianca Lattanzi, Sergio Davi, Silvia Rosina, Nicoletta Solari, Stefano Lanni, Giulia Bracciolini, Alberto Martini, Angelo Ravelli, Macrophage activation syndrome, Indian Journal of Rheumatology, 2012, 7, 1, 27

    CrossRef

  64. 64
    A Ravelli, A A Grom, E M Behrens, R Q Cron, Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment, Genes and Immunity, 2012, 13, 4, 289

    CrossRef

  65. 65
    Scott W. Canna, Edward M. Behrens, Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic Syndromes, Pediatric Clinics of North America, 2012, 59, 2, 329

    CrossRef

  66. 66
    Alberto Martini, Maladie de Still de l’enfant, évolution conceptuelle et thérapeutique, Revue du Rhumatisme Monographies, 2012, 79, 1, 3

    CrossRef

  67. 67
    Marije Oosting, Kathrin Buffen, Subbarao RK Malireddi, Patrick Sturm, Ineke Verschueren, Marije I Koenders, Frank L van de Veerdonk, Jos WM van der Meer, Mihai G Netea, Thirumala-Devi Kanneganti, Leo AB Joosten, Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3, Arthritis Research & Therapy, 2012, 14, 6, R247

    CrossRef

  68. 68
    Ross E Petty, Paediatric rheumatology: What has changed in last 10 years?, Indian Journal of Rheumatology, 2012, 7, 1, 1

    CrossRef

  69. 69
    Donald P. Goldsmith, Pericarditis, Journal of Clinical Rheumatology, 2012, 18, 5, 227

    CrossRef

  70. 70
    Sebastian FN Bode, Kai Lehmberg, Andrea Maul-Pavicic, Thomas Vraetz, Gritta Janka, Udo Stadt, Stephan Ehl, Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis, Arthritis Research & Therapy, 2012, 14, 3, 213

    CrossRef

  71. 71
    Isabelle Koné-Paut, Rhumatologie pédiatrique : quelles avancées ?, Revue du Rhumatisme Monographies, 2012, 79, 1, 1

    CrossRef

  72. 72
    R. Gurion, T. J. A. Lehman, L. N. Moorthy, Systemic Arthritis in Children: A Review of Clinical Presentation and Treatment, International Journal of Inflammation, 2012, 2012, 1

    CrossRef

  73. 73
    Alberto Martini, Systemic juvenile idiopathic arthritis, Autoimmunity Reviews, 2012, 12, 1, 56

    CrossRef

  74. 74
    M. Frosch, D. Holzinger, J. Roth, Systemische Verlaufsform der juvenilen idiopathischen Arthritis, Monatsschrift Kinderheilkunde, 2012, 160, 3, 217

    CrossRef

  75. 75
    Jaime de Inocencio Arocena, Terapia biológica en la artritis idiopática juvenil, Anales de Pediatría Continuada, 2012, 10, 6, 343

    CrossRef

  76. 76
    F.N.U. Nutan, A.J. Kanwar, D. Parsad, The effect of topically applied corticosteroids on interleukin 1β levels in patients with atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, 2012, 26, 8
  77. 77
    Yoo Jin Park, Yun Zhang, Ziliang Ao, Mark Meloche, Garth L. Warnock, Lucy Marzban, The IL-1 Receptor Antagonist Anakinra Enhances Survival and Function of Human Islets during Culture: Implications in Clinical Islet Transplantation, Canadian Journal of Diabetes, 2012, 36, 5, 244

    CrossRef

  78. 78
    Apostolos Kontzias, Petros Efthimiou, The Use of Canakinumab, a Novel IL-1β Long-Acting Inhibitor, in Refractory Adult-Onset Still's Disease, Seminars in Arthritis and Rheumatism, 2012, 42, 2, 201

    CrossRef

  79. 79
    K. Tenbrock, Therapie der juvenilen idiopathischen Arthritis (JIA), Monatsschrift Kinderheilkunde, 2012, 160, 3, 224

    CrossRef

  80. 80
    Alice Y. Chan, Diana Milojevic, Treatment of Juvenile Idiopathic Arthritis, Pediatric Annals, 2012, 41, 11, 1

    CrossRef

  81. 81
    Andreas Reiff, Treatment of Systemic Juvenile Idiopathic Arthritis with Tocilizumab - the Role of Anti-Interleukin-6 Therapy After a Decade of Treatment, Biologics in Therapy, 2012, 2, 1

    CrossRef

  82. 82
    Nicolino Ruperto, Hermine I. Brunner, Pierre Quartier, Tamás Constantin, Nico Wulffraat, Gerd Horneff, Riva Brik, Liza McCann, Ozgur Kasapcopur, Lidia Rutkowska-Sak, Rayfel Schneider, Yackov Berkun, Inmaculada Calvo, Muferet Erguven, Laurence Goffin, Michael Hofer, Tilmann Kallinich, Sheila K. Oliveira, Yosef Uziel, Stefania Viola, Kiran Nistala, Carine Wouters, Rolando Cimaz, Manuel A. Ferrandiz, Berit Flato, Maria Luz Gamir, Isabelle Kone-Paut, Alexei Grom, Bo Magnusson, Seza Ozen, Flavio Sztajnbok, Karine Lheritier, Ken Abrams, Dennis Kim, Alberto Martini, Daniel J. Lovell, Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis, New England Journal of Medicine, 2012, 367, 25, 2396

    CrossRef

  83. 83
    Rolando Cimaz, Davide Moretti, Ilaria Pagnini, Achille Marino, Luca Cantarini, Gabriele Simonini, What Do Cytokine Profiles Tell Us About Subsets of Juvenile Idiopathic Arthritis?, Current Rheumatology Reports, 2012, 14, 2, 150

    CrossRef

  84. 84
    D. Spoerl, Andreas J. Bircher, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2012,

    CrossRef

  85. You have free access to this content85
    Charles A. Dinarello, A clinical perspective of IL-1β as the gatekeeper of inflammation, European Journal of Immunology, 2011, 41, 5
  86. 86
    Nicolino Ruperto, Alberto Martini, Emerging drugs to treat juvenile idiopathic arthritis, Expert Opinion on Emerging Drugs, 2011, 16, 3, 493

    CrossRef

  87. 87
    Elizabeth D. Mellins, Claudia Macaubas, Alexei A. Grom, Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions, Nature Reviews Rheumatology, 2011, 7, 7, 416

    CrossRef

  88. 88
    Philip J. Hashkes, Pediatric rheumatology: Strengths and challenges of a new guide for treating JIA, Nature Reviews Rheumatology, 2011, 7, 7, 377

    CrossRef

  89. 89
    Sana S Siddique, Rajiv Shah, Ana M Suelves, Charles Stephen Foster, Road to remission: a comprehensive review of therapy in uveitis, Expert Opinion on Investigational Drugs, 2011, 20, 11, 1497

    CrossRef

  90. 90
    Gerd Horneff, Treatment options with biologics for juvenile idiopathic arthritis, International Journal of Clinical Rheumatology, 2011, 6, 3, 305

    CrossRef

  91. 91
    Keith A. Sikora, Alexei A. Grom, Update on the pathogenesis and treatment of systemic idiopathic arthritis, Current Opinion in Pediatrics, 2011, 23, 6, 640

    CrossRef